ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 138

Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis

Zihua Hu1, Kaiyu Jiang2, Mark B. Frank3, Yanmin Chen2 and James Jarvis4, 1Center for Computational Research, University at Buffalo, Buffalo, NY, 2Pediatrics, University at Buffalo, Buffalo, NY, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Pediatrics, SUNY Buffalo School of Medicine, Buffalo, NY

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Gene Expression, juvenile idiopathic arthritis (JIA) and neutrophils, MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Title: Genetics and Pathogenesis Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: We have previously shown that neutrophils in children with polyarticular juvenile idiopathic arthritis (JIA) display abnormal transcriptional patterns linked to fundamental metabolic derangements. These transcriptional abnormalities include complex re-ordering of miRNA-RNA expression networks. In the current study, we sought to determine the effects of therapy of the reorganization of miRNA-RNA networks in polyarticular JIA.

Methods: In this cross-sectional analysis, we studied children with untreated, active JIA (ADU-n=35), 26 children with active disease on therapy with methotrexate + etanercept (ADT), and 14 children with inactive disease also on therapy (ID). We used Affymetrix exon and miRNA microarrays to identify expressed transcripts and compared results to findings from 35 healthy control (HC) children.

Results: Computational modeling demonstrated substantial re-ordering of miRNA-RNA networks after the initiation of therapy. Each of the 3 disease states, i.e., ADU, ADT, and ID, was associated with its own distinct transcriptional profile that showed only modest overlaps with the other 2. Gene ontology analysis corroborated this finding, as the genes showing differential expression between each of the disease states and HC were associated with different biological functions. Among the networks, the ADT state differed the most from HC while ID more strongly resembled HC. Computational modeling demonstrated complex interactions between transcription factors and miRNA that determine the gene expression signatures of each disease state.

Conclusion: Therapy for JIA induces substantial re-organization of neutrophil transcriptomes. It is interesting to note that each of the different treatment stages, which were derived from clinical observations (Wallace criteria), appear to be biologically distinct. These findings affirm the value of using the Wallace criteria for staging treatment response in JIA.


Disclosure: Z. Hu, None; K. Jiang, None; M. B. Frank, None; Y. Chen, None; J. Jarvis, None.

To cite this abstract in AMA style:

Hu Z, Jiang K, Frank MB, Chen Y, Jarvis J. Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/modeling-transcriptional-rewiring-in-neutrophils-through-the-course-of-treated-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modeling-transcriptional-rewiring-in-neutrophils-through-the-course-of-treated-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology